高级搜索

晚期乳腺癌脑转移危险因素分析

张 杰, 李淑芬, 史业辉, 郝春芳, 董国雷, 佟仲生

张 杰, 李淑芬, 史业辉, 郝春芳, 董国雷, 佟仲生. 晚期乳腺癌脑转移危险因素分析[J]. 肿瘤防治研究, 2014, 41(05): 447-451. DOI: 10.3971/j.issn.1000-8578.2014.05.023
引用本文: 张 杰, 李淑芬, 史业辉, 郝春芳, 董国雷, 佟仲生. 晚期乳腺癌脑转移危险因素分析[J]. 肿瘤防治研究, 2014, 41(05): 447-451. DOI: 10.3971/j.issn.1000-8578.2014.05.023
ZHANG Jie, LI Shufen, SHI Yehui, HAO Chunfang, DONG Guolei, TONG Zhongsheng. Risk Factors for Brain Metastases from Advanced Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 447-451. DOI: 10.3971/j.issn.1000-8578.2014.05.023
Citation: ZHANG Jie, LI Shufen, SHI Yehui, HAO Chunfang, DONG Guolei, TONG Zhongsheng. Risk Factors for Brain Metastases from Advanced Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 447-451. DOI: 10.3971/j.issn.1000-8578.2014.05.023

晚期乳腺癌脑转移危险因素分析

基金项目: 天津市抗癌重大专项攻关计划资助项目(12ZCDZSY16200)
详细信息
    作者简介:

    张杰(1985-),女,硕士,住院医师,主要从事乳腺癌基础与临床研究

    通信作者:

    佟仲生,E-mail: tonghang@medmail.com.cn

  • 中图分类号: R737.9

Risk Factors for Brain Metastases from Advanced Breast Cancer

  • 摘要: 目的 分析晚期乳腺癌脑转移危险因素,指导临床筛选脑转移高危患者。方法 应用卡方检验及t检验进行单变量分析,对筛选出的脑转移危险因素进行多变量Logistic回归分析。结果 单变量分析显示,肿瘤最长径、阳性淋巴结数目、分子分型、人类表皮生长因子受体2(human epidermal growth factor receptor 2,HER2)、辅助化疗、无病生存时间、肺转移、局部复发、淋巴结转移9项因素有统计学意义(P<0.05)。多变量Logistic回归分析显示,术后辅助化疗不标准(P<0.001)、存在肺转移(P=0.003)及HER2阳性(P=0.003)为晚期乳腺癌脑转移的高危因素;所得Logistic回归方程对脑转移的预测正确率为73.9%。结论 晚期乳腺癌脑转移高危因素为术后辅助化疗不标准、存在肺转移及HER2阳性。

     

    Abstract: Objective To analyze the risk factors for brain metastasis from advanced breast cancer and provide clinical guide to screen high risk patients for brain metastasis. Methods T test and Chi-square Test were used for univariate analysis to find out the risk factors for brain metastasis, and these factors were analyzed by multivariable logistic regression analysis. Results Univariate analysis showed that 9 risk factors, such as tumor diameter, number of involved positive lymph nodes, molecular typing, HER2, adjuvant chemotherapy, disease-free survival, lung metastasis, local recurrence and lymph node metastasis, were statistically signifi cant for brain metastasis(P<0.05). Multivariable logistic regression analysis showed nonstandard adjuvant chemotherapy(P<0.001), lung metastasis(P=0.003) and HER2 positive(P=0.003) were high risk factors for brain metastasis from advanced breast cancer. The accuracy of prediction based on logistic regress equation for the brain metastases was 73.9%. Conclusion Risk factors for brain metastasis from advanced breast cancer are nonstandard adjuvant chemotherapy, lung metastasis and HER2 positive.

     

  • [1] Lassman AB , DeAngelis LM. Brain metastases[J]. Neurol Clin,2003,21(1):1-23,vii.
    [2] Weil RJ, Palmieri DC, Bronder JL, et al. Breast cancer metastasis to the central nervous system[J]. Am J Pathol,2005,167(4):913-20.
    [3] Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer[J]. J Clin Oncol,2004,22(17):3608-17.
    [4] Dawood S, Broglio K, Esteva FJ, et al. Defining prognosis for women with breast cancer and CNS metastases by HER2 status[J]. Ann Oncol,2008,19(7):1242-8.
    [5] Pestalozzi BC, Zahrieh D, Price KN, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)[J]. Ann Oncol,2006,17(6): 935-44.
    [6] Graesslin O, Abdulkarim BS, Coutant C, et al. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer[J]. J Clin Oncol,2010,28(12):2032-7.
    [7] Liu FS, Pathological classfi cation of tumors in China[M].Shanghai: Scientific Technical Documentation Press,2005,9,400-1.[刘 复生.中国肿瘤病理学分类[M].上海:科学技术文献出版 社,2005,9,400-1.]
    [8] Fattaneh A, Tavassoli, Peter Devilee. World Health Organization classifi cation of tumours pathology and genetics of tumours of the breast and female genital organs[M]. Lyon,IARC press,2003:10.
    [9] Hammond ME, Hayes DF, Wolff AC, et al. American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer[J]. J Oncol Pract,2010,6(4):195-7.
    [10] Wolff AC, Hammond ME, Schwartz JN, et a1. American society of clinical oncology/college of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer [J]. Arch Pathol Lab Med,2007,131(1):18-43.
    [11] Perou CM, Sørlie T, Eisen MB, et al . Molecular portraits of human breast tumors[J]. Nature,2000,406(6797):747-52.
    [12] Pestalozzi BC, Zahrieh D, Price KN, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)[J]. Ann Oncol,2006,17(6):935-44.
    [13] Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung[J]. Nature,2005,436(7050):518-24.
    [14] Gupta GP, Nguyen DX, Chiang AC, et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis[J]. Nature,2007,446(7137):765-70.
    [15] Miller KD, Weathers T, Haney LG, et al. Occult central nervous system involvement in patients with metastatic breast cancer: Prevalence, predictive factors and impact on overall survival[J]. Ann Oncol,2003,14(7),1072-7.
计量
  • 文章访问数:  1479
  • HTML全文浏览量:  468
  • PDF下载量:  972
  • 被引次数: 0
出版历程
  • 刊出日期:  2014-05-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭